Viewing StudyNCT00300274



Ignite Creation Date: 2024-05-05 @ 4:43 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00300274
Status: COMPLETED
Last Update Posted: 2012-08-16
First Post: 2006-03-06

Brief Title: Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Graft Rejection
Keywords:
Name View
survival View
Everolimus View
heart transplant View
heart disease View
transplantation View
heart IVUS assessment at 12 months View
rate of graft loss View
acute rejection episodes View